Futura Medical Statistics
Total Valuation
Futura Medical has a market cap or net worth of GBP 7.15 million. The enterprise value is 3.46 million.
Market Cap | 7.15M |
Enterprise Value | 3.46M |
Important Dates
The next estimated earnings date is Friday, December 12, 2025.
Earnings Date | Dec 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Futura Medical has 304.13 million shares outstanding. The number of shares has increased by 0.70% in one year.
Current Share Class | 304.13M |
Shares Outstanding | 304.13M |
Shares Change (YoY) | +0.70% |
Shares Change (QoQ) | -0.09% |
Owned by Insiders (%) | 10.36% |
Owned by Institutions (%) | 69.04% |
Float | 241.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.90 |
PB Ratio | 2.35 |
P/TBV Ratio | 2.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | 15.43 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.55 |
EV / Sales | 0.44 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.85 |
Financial Position
The company has a current ratio of 2.23
Current Ratio | 2.23 |
Quick Ratio | 2.11 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -115.97% and return on invested capital (ROIC) is -72.54%.
Return on Equity (ROE) | -115.97% |
Return on Assets (ROA) | -52.66% |
Return on Invested Capital (ROIC) | -72.54% |
Return on Capital Employed (ROCE) | -185.87% |
Revenue Per Employee | 566,185 |
Profits Per Employee | -449,614 |
Employee Count | 14 |
Asset Turnover | 1.06 |
Inventory Turnover | 166.31 |
Taxes
In the past 12 months, Futura Medical has paid 32,835 in taxes.
Income Tax | 32,835 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.58% in the last 52 weeks. The beta is 0.58, so Futura Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | -92.58% |
50-Day Moving Average | 7.69 |
200-Day Moving Average | 12.31 |
Relative Strength Index (RSI) | 19.50 |
Average Volume (20 Days) | 3,750,349 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Futura Medical had revenue of GBP 7.93 million and -6.29 million in losses. Loss per share was -0.02.
Revenue | 7.93M |
Gross Profit | 5.11M |
Operating Income | -6.30M |
Pretax Income | -6.26M |
Net Income | -6.29M |
EBITDA | -6.18M |
EBIT | -6.30M |
Loss Per Share | -0.02 |
Balance Sheet
The company has 3.69 million in cash and n/a in debt, giving a net cash position of 3.69 million or 0.01 per share.
Cash & Cash Equivalents | 3.69M |
Total Debt | n/a |
Net Cash | 3.69M |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 3.05M |
Book Value Per Share | 0.01 |
Working Capital | 2.58M |
Cash Flow
In the last 12 months, operating cash flow was 463,241 and capital expenditures -903,732, giving a free cash flow of -440,491.
Operating Cash Flow | 463,241 |
Capital Expenditures | -903,732 |
Free Cash Flow | -440,491 |
FCF Per Share | -0.00 |
Margins
Gross margin is 64.49%, with operating and profit margins of -79.48% and -79.41%.
Gross Margin | 64.49% |
Operating Margin | -79.48% |
Pretax Margin | -79.00% |
Profit Margin | -79.41% |
EBITDA Margin | -77.91% |
EBIT Margin | -79.48% |
FCF Margin | n/a |
Dividends & Yields
Futura Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.70% |
Shareholder Yield | n/a |
Earnings Yield | -88.07% |
FCF Yield | -6.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Futura Medical has an Altman Z-Score of -1.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.31 |
Piotroski F-Score | 3 |